Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms
Clinical trial NCT01112644 · COMPLETED
Trial details
- NCT number
- NCT01112644
- Sponsor
- Mundipharma Research GmbH & Co KG
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-06-01
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.